Rankings
▼
Calendar
SAVA Q4 2015 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$115M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$3,620
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-0.69
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$3M
Stock-Based Comp.
$818,000
Balance Sheet
Total Assets
$32M
Total Liabilities
$3M
Stockholders' Equity
$29M
Cash & Equivalents
$31M
← FY 2015
All Quarters
Q1 2016 →